Acquired Coagulation Factor V Inhibitor That Was Successfully Treated with Oral Corticosteroid Therapy-Reference-Cited by-同舟云学术

Acquired Coagulation Factor V Inhibitor That Was Successfully Treated with Oral Corticosteroid Therapy

Published:2021-08-15 Issue:16 Volume:60 Page:2663-2666
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Yokota Yoshihiro¹,Inatomi Osamu²,Nakagawa Minami³,Kakuda Kazuki¹,Hiroe Kousuke¹,Sakai Shigeki¹,Osaki Rie¹,Iwasa Masaki²,Kawahara Masahiro²,Kito Katsuyuki²,Andoh Akira²,Bamba Hiromichi¹

Affiliation:

1. Department of Gastroenterology, Nagahama Red Cross Hospital, Japan

2. Department of Medicine, Shiga University of Medical Science, Japan

3. Department of Clinical Laboratory Medicine, Nagahama Red Cross Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/60/16/60_7453-21/_pdf

Reference16 articles.

1. 1. Franchini M, Lippi G. Acquired factor V inhibitors: a systematic review. J Thromb Thrombolysis 31: 449-457, 2011.

2. 2. Olson NJ, Robert D, Hedayat AA, Liu X, Ornstein DL. Fatal hemorrhage due to a spontaneous factor V inhibitor with lupus anticoagulant properties. Blood Coagul Fibrinolysis 28: 407-410, 2017.

3. 3. Olson NJ, Ornstein DL. Factor V inhibitors: a diagnostic and therapeutic challenge. Arch Pathol Lab Med 141: 1728-1731, 2017.

4. 4. Ashizawa M, et al. Acquired factor V inhibitor associated with life-threatening bleeding and a mixing test result that indicated coagulation factor deficiency. Hematology 18: 300-304, 2013.

5. 5. Franchini M, Lippi G, Favaloro EJ. Acquired inhibitors of coagulation factors: part II. Semin Thromb Hemost 38: 447-453, 2012.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Considerations for simultaneous detection of autoantibodies to coagulation factor and lupus anticoagulant;Exploration of Immunology;2023-08-30

2. Delayed spontaneous remission of acquired factor V inhibitor refractory to immunosuppressive therapy with pregnancy-associated improvement;Pathology and Oncology Research;2023-06-02